Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.796
Filtrar
1.
Zhonghua Shao Shang Za Zhi ; 36(12): 1149-1158, 2020 Dec 20.
Artigo em Chinês | MEDLINE | ID: mdl-33379851

RESUMO

Objective: To explore the clinical efficacy of different modes of continuous negative pressure wound therapy (NPWT) on venous ulcer wounds of lower limbs, and to analyze the influencing factors. Methods: From January 2018 to December 2019, 53 patients with venous ulcer of lower limbs who met the inclusion criteria and hospitalized in the Affiliated Hospital of Jiangnan University were recruited in this prospective randomized controlled study. According to the random number table, the patients were divided into single negative pressure therapy (SNPT) group (19 patients, 11 males and 8 females), cyclic alternating negative pressure therapy (CANPT) group (17 patients, 12 males and 5 females), and routine dressing change (RDC) group (17 patients, 10 males and 7 females), aged (47±11), (49±10), and (47±10) years respectively. After admission, patients in SNPT group were given continuous NPWT with the single negative pressure setting at -13.3 kPa, patients in CANPT group were also given continuous NPWT but with the cyclic alternating negative pressure setting from -16.0 to -10.7 kPa, while patients in RDC group were given dressing change with vaseline gauze soaked with iodophor. The wound healing rate was calculated on treatment day 7 and 14. Transcutaneous oxygen pressure (TcPO(2)) around the wound was detected by TcPO(2) meter before treatment and on treatment day 7 and 14. The wound exudate/drainage fluid was collected on treatment day 1, 4, 7, 10, and 14, with the pH value measured using a pH meter, and the volume of exudate/drainage fluid recorded. Before treatment and on treatment day 7 and 14, venous blood was collected to detect the serum levels of interleukin 1ß (IL-1ß), IL-6, tumor necrosis factor α(TNF-α), transforming growth factor-ß(1) (TGF-ß(1)), vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). Before treatment and on treatment day 7 and 14, wound exudates were collected for bacterial culture, and Visual Analogue Scale and Hamilton Anxiety Scale were used to evaluate the degree of wound pain and anxiety of patients respectively. The length of hospital stay and the total treatment cost were counted. Analysis of variance for repeated measurement, one-way analysis of variance, least significant difference test, Kruskal Wallis H test, Mann Whitney U test, chi-square test, Fisher's exact probability method test, and Bonferroni correction were used to analyze the data. According to the wound healing rate on treatment day 14, the efficiency of patients were divided into two grades of significant healing with wound healing rate≥70% and non significant healing with wound healing rate<70%. According to the two categories of wound healing rate as dependent variables, the levels of TcPO(2), IL-1ß, IL-6, TNF-α, TGF-ß(1), VEGF, bFGF levels and bacterial detection, wound pain and anxiety before treatment, wound exudate/drainage fluid volume and pH value on treatment day 1 were taken as covariates, and binary classification multifactor logistic regression analysis was used to analyze the risk factors of significant wound healing. Results: (1) On treatment day 7, the wound healing rate of patients in SNPT group was (33±10) %, which was significantly higher than (24±9) % of RDC group (P<0.05). On treatment day 14, the wound healing rates of patients in SNPT group and CANPT group were (71±15)% and (66±18)%, respectively, which were significantly higher than (45±19)% of RDC group (P<0.01). (2) Compared with those of RDC group, the TcPO(2) value around the wound of patients was significantly increased in SNPT group on treatment day 14 and in CANPT group on treatment day 7 and 14 (P<0.05 or P<0.01), the pH value of wound drainage fluid of patients was significantly decreased in SNPT group on treatment day 10 and 14 and in CANPT group on treatment day 7 and 14 (P<0.05), the volume of wound drainage fluid of patients was significantly reduced in SNPT group on treatment day 10 and 14 and in CANPT group on treatment day 7, 10, and 14 (Z=-4.060, -4.954, -2.413, -4.085, -4.756, P<0.05 or P<0.01), the serum levels of IL-1ß, IL-6, and TNF-α of patients were significantly decreased in SNPT group and CANPT group on treatment day 7 and 14 (P<0.01), the serum level of TGF-ß(1) of patients was significantly increased in CANPT group on treatment day 14 (P<0.05), the serum levels of VEGF and bFGF were significantly increased in SNPT group and CANPT group on treatment day 14 (P<0.01), the bacteria detection proportion of wound exudate, wound pain, and anxiety scores of patients were significantly decreased in SNPT group and CANPT group on treatment day 7 and 14 (P<0.01). Compared between the negative pressure therapy two groups, except the wound pain score of patients in CANPT group was significantly lower than that in SNPT group (P<0.01) on treatment day 7, the other indicators mentioned above were similar. (3) The length of hospital stay of patients in SNPT group was similar to that in CANPT group (P>0.05), which were significantly shorter than the time in RDC group (P<0.01). The total treatment cost of patients among the three groups was similar (F=1.766, P>0.05). (4) Before treatment, the serum levels of TNF-α and bFGF, TcPO(2) around the wound, and the degree of wound pain were risk factors for significant wound healing (odds ratio=1.109, 0.950, 1.140, 2.169, 95% confidence interval=1.012-1.217, 0.912-0.988, 1.008-1.290, 1.288-3.651, P<0.05 or P<0.01). Conclusions: Clinical application of continuous NPWT under single negative pressure mode and cyclic alternating negative pressure mode has a positive effect on improving the wound base and healing rate of venous ulcer of lower limbs. But cyclic alternating negative pressure mode is significantly more effective than single negative pressure mode in improving TcPO(2) around the wound, reducing wound pH value, reducing exudate volume and relieving pain. The serum levels of TNF-α and bFGF, TcPO(2) around the wound and the degree of wound pain were the risk factors that affect the wound healing significantly.


Assuntos
Tratamento de Ferimentos com Pressão Negativa , Úlcera Varicosa , Adulto , Feminino , Humanos , Extremidade Inferior , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Resultado do Tratamento , Úlcera Varicosa/terapia , Fator A de Crescimento do Endotélio Vascular
2.
An Bras Dermatol ; 95 Suppl 1: 1-18, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33371937

RESUMO

BACKGROUND: Chronic leg ulcers affect a large portion of the adult population and cause a significant social and economic impact, related to outpatient and hospital care, absence from work, social security expenses, and reduced quality of life. The correct diagnosis and therapeutic approach are essential for a favorable evolution. OBJECTIVE: To gather the experience of Brazilian dermatologists, reviewing the specialized literature to prepare recommendations for the diagnosis and treatment of the main types of chronic leg ulcers. METHODS: Seven specialists from six university centers with experience in chronic leg ulcers were appointed by the Brazilian Society of Dermatology to reach a consensus on the diagnosis and therapeutic management of these ulcers. Based on the adapted DELPHI methodology, relevant elements were considered in the diagnosis and treatment of chronic leg ulcers of the most common causes; then, the recent literature was analyzed using the best scientific evidence. RESULTS: The following themes were defined as relevant for this consensus - the most prevalent differential etiological diagnoses of chronic leg ulcers (venous, arterial, neuropathic, and hypertensive ulcers), as well as the management of each one. It also included the topic of general principles for local management, common to chronic ulcers, regardless of the etiology. CONCLUSION: This consensus addressed the main etiologies of chronic leg ulcers and their management based on scientific evidence to assist dermatologists and other health professionals and benefit the greatest number of patients with this condition.


Assuntos
Dermatologia , Úlcera da Perna , Úlcera Varicosa , Adulto , Brasil , Consenso , Humanos , Úlcera da Perna/diagnóstico , Úlcera da Perna/terapia , Qualidade de Vida , Úlcera Varicosa/diagnóstico , Úlcera Varicosa/terapia
3.
Medicine (Baltimore) ; 99(32): e21608, 2020 Aug 07.
Artigo em Inglês | MEDLINE | ID: mdl-32769918

RESUMO

BACKGROUND: Venous leg ulcers (VLUs) are common throughout the world, which seriously affects the patient's work and life. Relevant researches suggested that sclerosing foam (SF) has potential benefits for VLUs. However, there is no consistent conclusion. The purpose of our study is to assess whether SF is effective and safe for VLUs. METHODS: Relevant clinical randomized controlled trials will be obtained from a search of 8 databases (with no language restrictions) from their inception to May 2020: PubMed, the Cochrane Library, EMBASE, Web of Science, China National Knowledge Infrastructure Database, Wanfang Database, China Science and Technology Journal Database, and Chinese Biological Medicine. Data will be analyzed using RevMan 5.3 after literature screening and data extraction according to predefined inclusion and exclusion criteria. Cochrane Collaboration Risk of bias Tool will be applied in evaluating the quality of enrolled articles. The primary outcome is Closure of venous leg ulcers, ulcer healing rate, adverse events related to SF. The secondary outcomes include ulcer healing time, ulcer recurrence rate, pain. Risk ratio will be used for categorical data; mean differences will be used for measurement data. Where possible and appropriate, meta-analysis will be performed for each outcome. RESULTS: To clarify whether Sclerosing foam can be safe and efficient on treating venous leg ulcers. CONCLUSION: Our review will provide useful information to judge whether Sclerosing Foam is an effective and safe intervention for patients with venous leg ulcers.


Assuntos
Bandagens/normas , Protocolos Clínicos , Células Espumosas , Soluções Esclerosantes/uso terapêutico , Úlcera Varicosa/terapia , Humanos , Perna (Membro)/anormalidades , Perna (Membro)/irrigação sanguínea , Perna (Membro)/fisiopatologia , Metanálise como Assunto , Soluções Esclerosantes/normas , Revisões Sistemáticas como Assunto
5.
J Wound Ostomy Continence Nurs ; 47(2): 173-181, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32150141

RESUMO

PURPOSE: The purpose of this study was to investigate the use of an mHealth application (app), self-management physical activity intervention FOOTFIT with an added patient-provider connectivity feature (FOOTFIT+), that was designed to strengthen the lower extremities of minimally ambulatory individuals with venous leg ulcers (VLUs). DESIGN: Randomized controlled trial. SUBJECTS AND SETTING: Twenty-four adults 18 years and older with VLUs being treated in 2 wound clinics in the Southeastern United States participated in this study. METHODS: Preliminary estimates and 95% confidence intervals for the medians of short-term functional impacts on foot function, strength, ankle range of motion, walking capacity, depression, and physical functioning were obtained pre- and postassessment after the 6-week intervention trial. RESULTS: There were negligible changes in either group for foot function. It is noted that both groups experienced substantial foot and ankle impairment at baseline. The greatest improvement in range of motion was noted in the FOOTFIT group for dorsiflexion of the right ankle (4.6 ± 5.22 lb/in over baseline) whereas strength decreased in both ankles for dorsiflexion and plantar flexion in the FOOTFIT+ group. No improvements were noted in walking distance or physical health for FOOTFIT (slight decrease -2.9 ± 5.6) and FOOTFIT+ (slight increase 3.0 ± 6.6) during the 6-week study period. CONCLUSIONS: In a minimally ambulatory population with VLUs, our mHealth FOOTFIT intervention composed of progressive exercise "boosts" demonstrated minimal short-term effects. We recommend engagement with the app for a longer period to determine longer-term outcomes of lower extremity function.


Assuntos
Exercício Físico/psicologia , Perna (Membro)/irrigação sanguínea , Telemedicina/instrumentação , Úlcera Varicosa/terapia , Idoso , Feminino , Humanos , Perna (Membro)/anormalidades , Perna (Membro)/fisiopatologia , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Sudeste dos Estados Unidos , Telemedicina/métodos , Úlcera Varicosa/fisiopatologia
7.
Wounds ; 32(1): 11-21, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32155127

RESUMO

OBJECTIVE: This study evaluates the clinical and cost effectiveness of a 2-layer compression system (2LBA; 3M Coban Two-Layer Compression System; 3M, St Paul, MN) compared with other 2-layer (2LB) and 4-layer (4LB) compression systems in patients with noninfected venous leg ulcers (VLUs). METHODS: The MEDLINE, EMBASE, CINAHL, Cochrane Library, National Health Service (NHS) Economic Evaluation, and EconLit databases were searched from inception up to January 2017. The MEDLINE search was updated on March 31, 2017. Study selection, quality assessment, and data synthesis were undertaken in accordance with recommended standards. Findings were presented narratively. RESULTS: In total, 5 studies (N = 1509 patients) of mixed methodological quality were included. At 6 months, 2LBA achieved better ulcer healing in comparison with 2LBB (odds ratio [OR], 1.57; 95% confidence interval [CI], 1.10-2.24; P = .03) and 4LBA (OR, 1.93, 95% CI, 1.26-2.97; P = .05) in patients with newly diagnosed ulcers only. For a combined population with newly diagnosed and existing VLUs, healing outcomes were OR, 2.87; 95% CI, 1.06-7.77; P = .04, and OR, 16.51; 95% CI, 2.08-131.37; P = .008, for 2LBs and 4LBs, respectively. Results on slippage were inconclusive. Adverse events were infrequent and did not differ significantly between interventions. Lower 6-month NHS costs for the combined population (£2413 vs. £2707 or £2648) and for newly diagnosed patients (£3045 vs. £3842 or £4480) were observed comparing 2LBA with 2LBB or 4LBA. Also, 2LBA was associated with better health-related quality of life (HRQoL) at 6 months. CONCLUSIONS: Based on these findings, 2LBA may result in lower treatment costs and better ulcer healing and HRQoL compared with other multicomponent therapies, especially in patients with newly diagnosed VLUs. However, further high-quality research is needed, especially for outcomes such as slippage and bandage wear time.


Assuntos
Bandagens Compressivas/economia , Úlcera Varicosa/economia , Úlcera Varicosa/terapia , Bandagens Compressivas/efeitos adversos , Análise Custo-Benefício , Custos de Cuidados de Saúde , Humanos , Qualidade de Vida , Resultado do Tratamento , Cicatrização
8.
Am Fam Physician ; 101(3): 159-166, 2020 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-32003952

RESUMO

Chronic wounds are those that do not progress through a normal, orderly, and timely sequence of repair. They are common and are often incorrectly treated. The morbidity and associated costs of chronic wounds highlight the need to implement wound prevention and treatment guidelines. Common lower extremity wounds include arterial, diabetic, pressure, and venous ulcers. Physical examination alone can often guide the diagnosis. All patients with a nonhealing lower extremity ulcer should have a vascular assessment, including documentation of wound location, size, depth, drainage, and tissue type; palpation of pedal pulses; and measurement of the ankle-brachial index. Atypical nonhealing wounds should be biopsied. The mainstay of treatment is the TIME principle: tissue debridement, infection control, moisture balance, and edges of the wound. After these general measures have been addressed, treatment is specific to the ulcer type. Patients with arterial ulcers should be immediately referred to a vascular surgeon for appropriate intervention. Treatment of venous ulcers involves compression and elevation of the lower extremities, plus exercise if tolerated. Diabetic foot ulcers are managed by offloading the foot and, if necessary, treating the underlying peripheral arterial disease. Pressure ulcers are managed by offloading the affected area.


Assuntos
Cicatrização/fisiologia , Ferimentos e Lesões/terapia , Doença Crônica/terapia , Pé Diabético/fisiopatologia , Pé Diabético/terapia , Humanos , Lesão por Pressão/fisiopatologia , Lesão por Pressão/terapia , Úlcera Varicosa/fisiopatologia , Úlcera Varicosa/terapia , Ferimentos e Lesões/prevenção & controle
9.
Hautarzt ; 71(4): 301-308, 2020 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-32100054

RESUMO

For several decades, compression therapy, which is associated with few side effects, has been a basis for the conservative treatment of patients with phlebological and lymphological diseases. For the practical implementation of compression therapy, many different materials are available, some with system-specific advantages and disadvantages. Medical adaptive compression systems (MAK) are still a relatively new treatment option in Germany. Apart from the very good practical experience in clinical everyday life, the compilation of the scientific evidence of compression therapy also shows that the scientific data situation is significantly better than for many other medical areas, especially for the treatment of patients with venous diseases. It is important to note that compression therapy must reliably guarantee adequate compression pressure. If these conditions are met, it can be assumed on the basis of the currently available data that the clinical effectiveness of the different compression systems is comparably good. These aspects have now also been well tested for MAK, so that these analogies can be drawn. Therapists today can therefore choose between different, very effective therapy options and take individual factors, patient wishes and economic aspects into account when making their selection.


Assuntos
Bandagens Compressivas , Pele/irrigação sanguínea , Úlcera Varicosa/terapia , Varizes/terapia , Insuficiência Venosa/terapia , Alemanha , Humanos , Pressão , Meias de Compressão , Resultado do Tratamento
10.
Arch Immunol Ther Exp (Warsz) ; 68(1): 5, 2020 Feb 14.
Artigo em Inglês | MEDLINE | ID: mdl-32060631

RESUMO

Adipose tissue is a reliable source of mesenchymal stromal cells (MSC) for use in regenerative medicine. The aim of this pilot study was to describe the method, and assess the safety and the potential efficacy of transplantation of autologous adipose tissue-derived MSC for the treatment of chronic venous stasis ulcers. Study group consisted of 11 patients (mean age: 66.6 ± 9.5 years) with chronic venous stasis ulcers. Adipose tissue was harvested by tumescent-aspiration method. Stromal cells were separated using a dedicated closed system in a real-time bedside manner. The phenotype of cells was determined immediately after separation. Cell concentrate was implanted subcutaneously around the wound and the wound bed. All ulcers were assessed planimetrically before autotransplantation and every two weeks during the six-month follow-up. During the study all patients received standard local and general treatment. The preparation contained an average of 5.6 × 106 ± 4 × 106 cells per milliliter. The phenotype of 65-82% of transplanted cells expressed MSC markers: CD73+ CD90+ and CD34+. An improvement was observed in 75% of ulcers. The data showed highly significant negative correlation (p < 0.0001) between wound size and wound closure degree. There was no correlation of ulcer healing with other parameters evaluated, including age of the patients. No serious side effects were observed. Autotransplantation of adipose tissue stromal cells may be a safe and promising treatment method for chronic venous ulcers.


Assuntos
Tecido Adiposo/citologia , Transplante de Células-Tronco Mesenquimais/métodos , Úlcera Varicosa/terapia , Idoso , Biomarcadores/metabolismo , Doença Crônica , Feminino , Humanos , Masculino , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/metabolismo , Pessoa de Meia-Idade , Fenótipo , Projetos Piloto , Transplante Autólogo , Resultado do Tratamento , Úlcera Varicosa/patologia , Cicatrização/fisiologia
11.
Medicine (Baltimore) ; 99(8): e19317, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-32080149

RESUMO

Endovenous laser ablation (EVLA) and ultrasound-guided foam sclerotherapy (UGFS) have largely replaced traditional surgery for treatment of varicose veins (VVs) with active venous leg ulcers (VLUs), and multiple combined modes have emerged. A retrospective cohort study was performed to compare the effect of traditional surgery (high ligation and stripping followed with compression [compression plus HL-S]) to high ligation-endovenous laser ablation-foam sclerotherapy followed with compression (compression plus HL-EVLA-FS) on the treatment of active VLUs.Data of active VLUs treated in our center from 2008 to 2017 and followed up for 1 year were analyzed. The intervention measures in the first 5 years were compression plus HL-S, and in the following 5 years were compression plus HL-EVLA-FS. The primary outcome was ulcer healing time. The secondary outcomes were the VVs occlusion and clinical success as assessed by a change in venous clinical severity score (VCSS) and complications.The study included 120 patients and 200 patients treated with HL-S and HL-EVLA-FS, respectively, during 2008 to 2017. The average ulcer healing time were 2.3 ±â€Š2.4 and 1.7 ±â€Š1.7 months, respectively. Significant difference was found in the cumulative ulcers healing rate between the two groups (Hazard ratio [HR] and 95% confidence interval [CI] was respectively 1.458 and 1.140-1.865, P = .0002), but no difference was found in the VVs occlusion (HR and 95% CI was respectively 1.005 and 0.774-1.3071, P = .967). Significant difference occurred in 6 months and 12 months post-operatively in the VCSS change and in the procedure data and some complications between the 2 groups.In conclusion, the treatment of HL-EVLA-FS can accelerate the healing of VLUs, improve the VCSS and present superior procedure data. However, no advantage could be found in the VVs occlusion compared with control group.


Assuntos
Terapia a Laser , Ligadura , Escleroterapia , Úlcera Varicosa/terapia , Procedimentos Cirúrgicos Vasculares , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Veia Safena/cirurgia , Índice de Gravidade de Doença , Meias de Compressão , Cicatrização
12.
Adv Ther ; 37(Suppl 1): 19-24, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31970660

RESUMO

Venous leg ulcers (VLUs) are the most severe manifestation of chronic venous disease (CVD). Due to their chronic nature, high recurrence rate and slow healing time, VLUs account for 80% of all leg ulcers seen in patients with CVD. VLUs impose a heavy burden on patients that reduces their quality of life; VLUs also represent a major socioeconomic impact due to the cost and duration of care. The primary medical approach to treating VLUs is local compression therapy in combination with venoactive drug (VAD) pharmacotherapy to promote the reduction of the inflammatory reaction initiated by venous hypertension. Micronized purified flavonoid fraction (MPFF; Daflon®) is the most widely prescribed VAD. MPFF counteracts the pathophysiologic mechanisms of CVD and ulceration and has proven to be an effective adjunct to compression therapy in patients with large and chronic VLUs. Two other non-VAD drugs, pentoxifylline and sulodexide, have also been shown to improve VLU healing and are also recommended in addition to compression therapy. However, MPFF is the only VAD with the highest strength of recommendations in the 2018 guidelines for the healing of VLUs.


Assuntos
Úlcera Varicosa/terapia , Fármacos Cardiovasculares/uso terapêutico , Doença Crônica , Bandagens Compressivas , Diosmina/uso terapêutico , Flavonoides/uso terapêutico , Humanos , Qualidade de Vida , Índice de Gravidade de Doença , Cicatrização/fisiologia
13.
Cochrane Database Syst Rev ; 1: CD001836, 2020 01 20.
Artigo em Inglês | MEDLINE | ID: mdl-31978262

RESUMO

BACKGROUND: It is estimated that up to 1% of people in high-income countries suffer from a leg ulcer at some time in their life. The majority of leg ulcers are associated with circulation problems; poor blood return in the veins causes venous ulcers (around 70% of ulcers) and poor blood supply to the legs causes arterial ulcers (around 22% of ulcers). Treatment of arterial leg ulcers is directed towards correcting poor arterial blood supply, for example by correcting arterial blockages (either surgically or pharmaceutically). If the blood supply has been restored, these arterial ulcers can heal following principles of good wound-care. Dressings and topical agents make up a part of good wound-care for arterial ulcers, but there are many products available, and it is unclear what impact these have on ulcer healing. This is the third update of a review first published in 2003. OBJECTIVES: To determine whether topical agents and wound dressings affect healing in arterial ulcers. To compare healing rates and patient-centred outcomes between wound dressings and topical agents. SEARCH METHODS: The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, Cochrane Central Register of Controlled Trials, MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature and Allied and Complementary Medicine databases, the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials register to 28 January 2019. SELECTION CRITERIA: Randomised controlled trials (RCTs), or controlled clinical trials (CCTs) evaluating dressings and topical agents in the treatment of arterial leg ulcers were eligible for inclusion. We included participants with arterial leg ulcers irrespective of method of diagnosis. Trials that included participants with mixed arterio-venous disease and diabetes were eligible for inclusion if they presented results separately for the different groups. All wound dressings and topical agents were eligible for inclusion in this review. We excluded trials which did not report on at least one of the primary outcomes (time to healing, proportion completely healed, or change in ulcer area). DATA COLLECTION AND ANALYSIS: Two review authors independently extracted information on the participants' characteristics, the interventions, and outcomes using a standardised data extraction form. Review authors resolved any disagreements through discussion. We presented the data narratively due to differences in the included trials. We used GRADE to assess the certainty of the evidence. MAIN RESULTS: Two trials met the inclusion criteria. One compared 2% ketanserin ointment in polyethylene glycol (PEG) with PEG alone, used twice a day by 40 participants with arterial leg ulcers, for eight weeks or until healing, whichever was sooner. One compared topical application of blood-derived concentrated growth factor (CGF) with standard dressing (polyurethane film or foam); both applied weekly for six weeks by 61 participants with non-healing ulcers (venous, diabetic arterial, neuropathic, traumatic, or vasculitic). Both trials were small, reported results inadequately, and were of low methodological quality. Short follow-up times (six and eight weeks) meant it would be difficult to capture sufficient healing events to allow us to make comparisons between treatments. One trial demonstrated accelerated wound healing in the ketanserin group compared with the control group. In the trial that compared CGF with standard dressings, the number of participants with diabetic arterial ulcers were only reported in the CGF group (9/31), and the number of participants with diabetic arterial ulcers and their data were not reported separately for the standard dressing group. In the CGF group, 66.6% (6/9) of diabetic arterial ulcers showed more than a 50% decrease in ulcer size compared to 6.7% (2/30) of non-healing ulcers treated with standard dressing. We assessed this as very-low certainty evidence due to the small number of studies and arterial ulcer participants, inadequate reporting of methodology and data, and short follow-up period. Only one trial reported side effects (complications), stating that no participant experienced these during follow-up (six weeks, low-certainty evidence). It should also be noted that ketanserin is not licensed in all countries for use in humans. Neither study reported time to ulcer healing, patient satisfaction or quality of life. AUTHORS' CONCLUSIONS: There is insufficient evidence to determine whether the choice of topical agent or dressing affects the healing of arterial leg ulcers.


Assuntos
Úlcera da Perna/terapia , Pomadas/uso terapêutico , Cicatrização , Administração Tópica , Artérias , Curativos Hidrocoloides , Humanos , Curativos Oclusivos , Ensaios Clínicos Controlados Aleatórios como Assunto , Úlcera Varicosa/terapia
16.
Rev Gaucha Enferm ; 41(spe): e20190146, 2020.
Artigo em Inglês, Português | MEDLINE | ID: mdl-31800800

RESUMO

OBJECTIVE: To evaluate the knowledge of patients with venous ulcers (VU) on their chronic disease, treatment, and prevention of complications, according to the Nursing Outcomes Classification-NOC. METHODS: This is a cross-sectional study conducted between 2017 and 2018 in a Brazilian hospital. The sample consisted of 38 patients with VU attended in outpatient nursing consultations. The study analyzed sociodemographic, clinical and nine indexes from the Knowledge: Chronic Disease Management (1847) of the NOC, assessed using a five-point Likert scale, analyzed using descriptive statistics. RESULTS: The mean of the result Knowledge: Chronic Disease Management (1847) was 3.56±1.42. The clinical index Procedures involved in treatment regimen had the highest mean 4.18±0.21, followed by Pain management strategies with 3.92±0.27. In the association between knowledge and healing, the best scores were in patients with at least one healed VU. CONCLUSION: The knowledge of the patients was moderate and it was necessary to promote educational actions according to individual demands.


Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Terminologia Padronizada em Enfermagem , Úlcera Varicosa/terapia , Idoso , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
17.
Hautarzt ; 71(1): 24-31, 2020 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-31845297

RESUMO

For the treatment of phlebological and lymphological diseases as well as constitutional edema diseases, a discussion of innovative concepts of medical compression therapy is essential. It is recommended that medical compression stockings should always be prescribed based on symptoms and with the lowest effective interface pressure to optimize the tolerability of compression therapy. Likewise, medical compression stockings with an integrated care formula, but also the application of additional skincare can improve the quality of life and compliance in patients with chronic venous insufficiency. Optimization of ulcer therapy can be achieved by using two-component compression stocking systems. These consist of an understocking and a firm outer compression stocking, which improve the venous and capillary hemodynamics with good wearing comfort and lead to the healing of venous ulcerations. Multicomponent compression bandages and short stretch bandages are proven in the decongestion phase of edema. Multicomponent bandages ensure a sustained interface pressure for at least 5 days and are ideal for outpatient treatment with less frequent dressing changes. For compression therapy in patients with arterial-venous leg ulcers (ABI [ankle brachial index] >0.5), specially developed "lite" versions of the multicomponent dressings can be used.


Assuntos
Meias de Compressão , Úlcera Varicosa , Insuficiência Venosa , Bandagens Compressivas , Humanos , Qualidade de Vida , Úlcera Varicosa/terapia , Insuficiência Venosa/terapia
18.
Rev. gaúch. enferm ; 41(spe): e20190146, 2020. tab, graf
Artigo em Inglês | LILACS, BDENF - Enfermagem | ID: biblio-1058526

RESUMO

Abstract Objective: To evaluate the knowledge of patients with venous ulcers (VU) on their chronic disease, treatment, and prevention of complications, according to the Nursing Outcomes Classification-NOC. Methods: This is a cross-sectional study conducted between 2017 and 2018 in a Brazilian hospital. The sample consisted of 38 patients with VU attended in outpatient nursing consultations. The study analyzed sociodemographic, clinical and nine indexes from the Knowledge: Chronic Disease Management (1847) of the NOC, assessed using a five-point Likert scale, analyzed using descriptive statistics. Results: The mean of the result Knowledge: Chronic Disease Management (1847) was 3.56±1.42. The clinical index Procedures involved in treatment regimen had the highest mean 4.18±0.21, followed by Pain management strategies with 3.92±0.27. In the association between knowledge and healing, the best scores were in patients with at least one healed VU. Conclusion: The knowledge of the patients was moderate and it was necessary to promote educational actions according to individual demands.


Resumen Objetivo: Evaluar el conocimiento de pacientes con úlcera venosa (UVe) en su enfermedad crónica, tratamiento y prevención de complicaciones, según la Nursing Outcomes Classification-NOC. Métodos: Estudio transversal entre 2017 y 2018 en hospital brasileño. La muestra consistió en 38 pacientes con UVes atendidos en consultas de enfermería ambulatorias. Analizamos los conocimientos sociodemográficos, clínicos y nueve indicadores NOC Conocimiento: Control de la Enfermedad Crónica ( 1847) evaluada por escala Likert de cinco puntos. El análisis fue estadístico descriptivo. Resultados: El promedio del resultado Conocimiento: Control del la Enfermedad Crónica (1847) fue de 3,56±1,42, los indicadores clínicos Procedimientos del régimen de tratamiento obtuvieron el mejor promedio de 4,18±0,21, seguidos del Estrategias de control del dolor con 3,92±0,27. En la asociación del conocimiento versus curación, se encontraron mejores puntuaciones en pacientes con menos una UVe sanada. Conclusiones: El conocimiento de los pacientes demostró ser moderado, con necesidad de promover acciones educativas de acuerdo con las demandas individuales.


Resumo Objetivo: Avaliar o conhecimento de pacientes com úlcera venosa (UVe) sobre a sua doença crônica, tratamento e prevenção de complicações, segundo a Nursing Outcomes Classification - NOC. Métodos: Estudo transversal realizado entre 2017 e 2018 em hospital brasileiro. A amostra foi de 38 pacientes com UVes atendidos em consulta de enfermagem ambulatorial. Foram analisados dados sociodemográficos, clínicos e nove indicadores do resultado NOC Conhecimento: Controle da Doença Crônica (1847) avaliados por escala Likert de cinco pontos. A análise foi estatística descritiva. Resultados: A média do resultado Conhecimento: controle da doença (1847) foi 3,56±1,42, o indicador clínico Procedimentos envolvidos no regime de tratamento obteve a melhor média 4,18±0,21, seguido de Estratégias de controle da dor com 3,92±0,27. Na associação do conhecimentoversuscicatrização os melhores escores foram em pacientes com pelo menos uma UVe cicatrizada. Conclusões: O conhecimento dos pacientes mostrou-se moderado havendo necessidade de promover ações educativas conforme demandas individuais.


Assuntos
Humanos , Masculino , Feminino , Idoso , Úlcera Varicosa/terapia , Conhecimentos, Atitudes e Prática em Saúde , Terminologia Padronizada em Enfermagem , Estudos Transversais , Pessoa de Meia-Idade
19.
Artigo em Inglês, Português | LILACS, BDENF - Enfermagem | ID: biblio-1051356

RESUMO

Objetivo: Avaliar a evolução da cicatrização de úlceras nos membros inferiores de pacientes em uso de bota de Unna associada ao shiatsu. Método: Estudo de caso realizado na Policlínica Regional no interior de Minas Gerais com sete indivíduos portadores de úlceras nos membros inferiores. A coleta de dados foi realizada durante o tratamento associado a terapia alternativa/complementar shiatsu. Os dados foram analisados por estatística descritiva. Resultados: A média de idade foi de 61,5 anos, dentre as patologias de base, seis tinham diabetes mellitus, quatro eram hipertensos. Na avaliação dos membros inferiores, observou-se: área média inicial da ferida: 73 cm2 área média final 24 cm2 . PUSH inicial 14,8 e final 8,8. Dor inicial 2,7 e final 0,14. Conclusão: Percebeu-se redução na área das feridas, na intensidade da dor, e no número de feridas, indicando que o tratamento convencional associado a terapia alternativa complementar pode ser benéfico


Objective: To evaluate the evolution of healing ulcers in the lower limbs of patients using Unna boot associated with shiatsu. Method: A case study carried out in the Regional Polyclinic in the interior of Minas Gerais, Brazil, with seven individuals with ulcers in the lower limbs. Data collection was performed during treatment associated with alternative/complementary shiatsu therapy. Data were analyzed by descriptive statistics. Results: The mean age was 61.5 years, among the underlying pathologies, six had diabetes mellitus, four were hypertensive. In the evaluation of the lower limbs, we observed: initial mean wound area: 73 cm2 final mean area 24 cm2 . Initial PUSH 14.8 and final 8.8. Initial pain 2.7 and final 0.14. Conclusion: Reduction in wound area, pain intensity, and number of wounds was observed, indicating that conventional treatment associated with complementary alternative therapy may be beneficial


Objetivo: Evaluar la evolución de la cicatrización de úlceras en los miembros inferiores de pacientes en uso de bota de Unna asociada al shiatsu. Método: Estudio de caso realizado en la Policlínica Regional en el interior de Minas Gerais con siete individuos portadores de úlceras en los miembros inferiores. La recolección de datos fue realizada durante el tratamiento asociado a shiatsu. Los datos fueron analizados por estadística descriptiva. Resultados: El promedio de edad fue de 61,5 años, entre las patologías de base, seis tenían diabetes mellitus, cuatro eran hipertensos. En la evaluación de los miembros inferiores, se observó: área media inicial de la herida: 73 cm2 área media final 24 cm2 . PUSH inicial 14,8 y final 8,8. Dolor inicial 2,7 y final 0,14. Conclusión: Se percibió reducción en el área de las heridas, en la intensidad del dolor, y en el número de heridas, indicando que el tratamiento convencional asociado a terapia alternativa complementaria puede ser benéfico


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Pé Diabético/terapia , Acupressão/métodos , Bandagens Compressivas , Úlcera Varicosa/terapia , Cicatrização , Terapias Complementares , Fatores de Risco
20.
J Vasc Nurs ; 37(4): 232-245, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31847977

RESUMO

The objective of this study was to compare the effectiveness of 2 bundles in venous leg ulcer healing. This study is a open, randomized, controlled clinical trial with parallel treatment, 1:1 allocation rate, and 24-week follow-up. Twenty-eight patients with venous leg ulcers of the lower limbs were allocated to 2 groups: group A (n = 14) and group B (n = 14). The mean age of the participants was 59.67 ± 11.95 years, and the mean ulcer surface area was 29.32 (±98.43) cm2. The primary outcome was ulcer healing. Secondary outcomes were wound area reduction rate, Pressure Ulcer Scale of Healing (PUSH) scores, and the presence and intensity of pain before, during and after dressing change. Two different bundles were applied in 2 phases to the randomized groups. All participants engaged in an educational activity, performed exercises, rested with legs elevated, received oral nutrition supplementation (Cubitan; Danone Nutricia), and had their ulcers cleaned with warm saline solution and biguanide polyhexanide solution (Prontosan; B. Braun). Topical therapy in the first phase was papain 2% or 4% for group A and 2% hydrogel for group B. Both groups received single-layer elastic compression therapy (SurePress; ConvaTec). In the second phase, group A received compression therapy with Unna boot (Viscopaste; Smith-Nephew) as the primary dressing, while group B received a cellulose membrane (Membracel; Vuelo Pharma) followed by the Unna boot (Viscopaste; Smith-Nephew).In group A, 71.42% of the ulcers healed; in group B, the figure was 64.28%. Wound area, PUSH scores, and the occurrence and intensity of pain decreased significantly and equivalently in groups A and B.Both bundles are effective in the treatment of venous leg ulcers and pain relief.


Assuntos
Perna (Membro) , Úlcera Varicosa/terapia , Cicatrização , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Dor , Meias de Compressão
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...